Intervention_type,intervention,Study_count
placebo,placebo,297
Drug,hydroxychloroquine,106
Other,standard care,98
Biological,convalescent plasma,84
Drug,azithromycin,35
Biological,mesenchymal stem cells,28
Drug,tocilizumab,28
Drug,ritonavir,26
Drug,saline,25
Drug,ivermectin,24
Drug,lopinavir,23
Drug,favipiravir,21
Drug,lopinavir/ritonavir,21
Drug,chloroquine,17
Drug,enoxaparin,16
Drug,remdesivir,16
Biological,blood sample,15
Device,oxygen,15
Drug,colchicine,14
Drug,methylprednisolone,14
Procedure,prone positioning,14
Drug,control,13
Drug,heparin,13
Biological,plasma,13
Drug,interferon,12
Dietary Supplement,vitamin c,12
Other,exercise,11
Drug,nitazoxanide,11
Drug,hydroxychloroquine / azithromycin,10
Dietary Supplement,vitamin d,10
Drug,anakinra,9
Other,questionnaire,9
Drug,ruxolitinib,8
Diagnostic Test,serology test,8
Drug,zinc,8
Drug,baricitinib,7
Drug,dexamethasone,7
Drug,losartan,7
Drug,nitric oxide,7
Drug,povidone/iodine,7
Radiation,radiotherapy,7
Other,telehealth,7
Biological,bcg,6
Diagnostic Test,biological samples,6
Drug,oseltamivir,6
Drug,sarilumab,6
Drug,cholecalciferol,5
Drug,clazakizumab,5
Drug,ly3819253,5
Drug,rivaroxaban,5
Drug,sofosbuvir,5
Drug,telmisartan,5
Drug,anticoagulation,4
Drug,arbidol,4
Drug,bromhexine hydrochloride,4
Drug,camostat mesilate,4
Drug,chloroquine/hydroxychloroquine,4
Drug,doxycycline,4
Biological,inactivated sars-cov-2 vaccine,4
Radiation,low,4
Drug,mavrilimumab,4
Combination Product,na-831,4
Diagnostic Test,nasopharyngeal swab,4
Biological,nk cells,4
Diagnostic Test,pcr,4
Drug,peginterferon,4
Drug,regn10933,4
Drug,supportive care,4
Behavioral,,3
Biological,adenovirus type 5 vector,3
Drug,aspirin,3
Other,best available therapy,3
Biological,biological,3
Other,blood,3
Behavioral,blood donation sms,3
Diagnostic Test,blood test,3
Biological,bnt162b1,3
Drug,budesonide,3
Biological,chadox1,3
Drug,clopidogrel,3
Drug,corticosteroid,3
Drug,daclatasvir,3
Drug,imatinib,3
Drug,immunoglobulin,3
Behavioral,information,3
Drug,lenzilumab,3
Biological,mrna-1273,3
Drug,nigella sativa,3
Dietary Supplement,probiotic,3
Drug,pulmozyme,3
Drug,ribavirin,3
Biological,saliva,3
Drug,sargramostim,3
Drug,sirolimus,3
Drug,soc,3
Other,survey,3
Procedure,therapeutic plasma exchange,3
Dietary Supplement,vitamin super b-complex,3
Biological,vpm1002,3
Drug,0.4 ml injectable solution,2
Biological,28-day schedule,2
Drug,acalabrutinib,2
Other,ace inhibitor,2
Drug,acetylsalicylic acid,2
Biological,ad26.cov2.s,2
Device,aeonose,2
Drug,antibiotics,2
Dietary Supplement,ayurveda,2
Biological,bacille calmette-guã©rin (bcg),2
Biological,best available care,2
Other,best supportive care,2
Drug,bevacizumab,2
Other,blood draw,2
Biological,bnt162b2,2
Drug,canakinumab,2
Drug,cannabidiol,2
Device,cellectraâ® 2000,2
Drug,ciclesonide,2
Diagnostic Test,conjunctival swab,2
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",2
Device,coviage,2
Device,cpap,2
Diagnostic Test,ct-scan,2
Drug,cumin,2
Drug,cyclosporine,2
Device,cytokine adsorption,2
Device,cytosorb,2
Drug,dapagliflozin,2
Behavioral,data collection,2
Drug,dipyridamole,2
Drug,edp1815,2
Drug,eidd-2801,2
Drug,famotidine,2
Combination Product,favipiravir/hydroxychloroquine,2
Biological,gam-covid-vac,2
Dietary Supplement,honey,2
Drug,hormones,2
Drug,ibrutinib,2
Drug,ibuprofen,2
Drug,icosapent ethyl,2
Device,igg,2
Device,igm antibodytest,2
Drug,iloprost,2
Drug,imu-838,2
Biological,ino-4800,2
Drug,interleukin,2
Drug,iodine,2
Other,kb109,2
Other,kb109 / self supportive care (ssc),2
Drug,kg,2
Biological,lanadelumab,2
Drug,ledipasvir,2
Device,lung ultrasound,2
Device,"magpro x100 stimulator, b70 fluid-cooled coil",2
Behavioral,mechanical ventilation,2
Behavioral,meditation,2
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-,2
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,2
Combination Product,mefloquine,2
Drug,melatonin,2
Drug,nafamostat mesilate,2
Device,nasal rinse,2
Drug,nigella sativa / black cumin,2
Biological,octagam,2
Drug,opaganib,2
Procedure,ophthalmologic exam,2
Other,phone call,2
Other,physical therapy,2
Drug,prednisone,2
Behavioral,preventive information,2
Drug,pul-042,2
Drug,pyronaridine-artesunate,2
Dietary Supplement,quercetin,2
Biological,ravulizumab,2
Biological,recombinant new coronavirus vaccine (cho cell) low-dose group,2
Biological,recombinant new coronavirus vaccine (cho cells) high-dose group,2
Drug,regn10933/regn10987 combination therapy,2
Drug,regn10987,2
Drug,regn10987 combination therapy,2
Biological,sars-cov-2 rs,2
Other,self supportive care (ssc),2
Other,self supportive care (ssc) alone,2
Biological,serum test,2
Drug,sevoflurane,2
Drug,siltuximab,2
Drug,soc / placebo,2
Drug,sofosbuvir/ledipasvir,2
Biological,stool collection,2
Drug,td-0903,2
Other,tele-yoga therapy,2
Biological,therapeutic plasma exchange (tpe),2
Drug,thromboprophylaxis,2
Drug,water,2
Other,yoga,2
Combination Product,- tocilizumab,1
Drug,-interferon nebulization,1
Other,"""calm"" is a mindfulness meditation mobile app",1
Drug,0.12% chg oral rinse,1
Drug,0.4ml inj syringe 0.4ml,1
Drug,0.67ml inj syringe,1
Other,0.9% saline,1
Drug,0.9%sodium chloride,1
Biological,10 to 14 days later,1
Drug,10% povidone-iodine nasal decolonization swab,1
Drug,10% povidone-iodine nasal decolonization swab/0.12% chg oral rinse,1
Drug,100 mg,1
Drug,1200 mg),1
Biological,14-day schedule,1
Drug,1600 mg),1
Drug,18f-î±vî²6-bp,1
Biological,2.2x10^10vp (qpcr) boost,1
Drug,20 mg prednisone for 14 days,1
Biological,21 - phase 2,1
Combination Product,4plants,1
Combination Product,4plants/azythromycin,1
Biological,5x10^10vp boost (qpcr),1
Other,6 months later,1
Other,a short video intervention,1
Other,a vignette intervention,1
Dietary Supplement,aã§aã­ palm berry extract - natural product,1
Biological,aapc,1
Diagnostic Test,aaz covid-19 rapid test,1
Drug,abx464,1
Device,accuchek inform ii platform,1
Drug,"ace inhibitor, angiotensin receptor blocker",1
Device,actigraphy,1
Behavioral,action (tara),1
Drug,activase,1
Drug,active comparator,1
Biological,ad5-ncov,1
Biological,adimrsc-2f,1
Biological,adsorbed covid-19 (inactivated) vaccine,1
Drug,aerosolized dnase,1
Other,after-each-case room disinfection,1
Biological,ag0301-covid19,1
Biological,ag0302-covid19,1
Other,albumine,1
Biological,allocetra-ots,1
Drug,allogeneic,1
Drug,alpha one antitrypsin,1
Biological,alum adjuvant,1
Procedure,alveolar,1
Drug,ambrisentan,1
Drug,amiodarone,1
Biological,ampion,1
Drug,anakinra/osoc,1
Drug,ang-3777,1
Other,anger message,1
Radiation,angiography scanner,1
Biological,angiotensin peptide (1-7) derived plasma,1
Drug,angiotensin receptor blockers,1
Drug,anise seed capsule,1
Drug,anluohuaxian,1
Biological,anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,1
Biological,anti-sars-cov-2 igt seropositivity,1
Diagnostic Test,"antibody rapid testing, mobile device image capture",1
Diagnostic Test,antibody test,1
Drug,antihypertensives,1
Other,anxiety,1
Behavioral,anxiety reduction training,1
Drug,apilimod dimesylate,1
Drug,apl-9,1
Other,apps,1
Drug,apremilast,1
Drug,aprepitant injectable emulsion,1
Drug,aprotinin,1
Other,arb,1
Drug,arbidol hydrochloride/interferon atomization,1
Other,ardsnet,1
Drug,argatroban,1
Dietary Supplement,artemesia annua,1
Drug,artemic,1
Drug,artesunate-amodiaquine,1
Dietary Supplement,asbrip,1
Drug,asc09,1
Drug,asc09f/oseltamivir,1
Dietary Supplement,ascorbic acid/zinc gluconate,1
Other,assembled mask,1
Drug,at-001,1
Drug,at-527,1
Combination Product,atazanavir,1
Combination Product,atazanavir/dexamethasone,1
Drug,ati-450,1
Drug,atorvastatin,1
Drug,atorvastatin 20mg,1
Drug,atovaquone,1
Drug,atovaquone/azithromycin,1
Behavioral,attention bias modification (abm),1
placebo,attention placebo,1
Drug,atyr1923,1
Procedure,auditory evoked potentials (aep),1
Procedure,auricular neuromodulation,1
Device,auricular percutaneous neurostimulation,1
Biological,autologous non-hematopoietic peripheral blood stem cells (nhpbsc),1
Drug,auxora,1
Biological,avdoralimab,1
Drug,avigan,1
Drug,aviptadil,1
Drug,aviptadil/standard care,1
Behavioral,award,1
Behavioral,award advice,1
Behavioral,award/covid-specific advice,1
Drug,azithromycin capsule,1
Drug,azoximer bromide,1
Biological,bactek-r,1
Behavioral,bandebereho fathers',1
Drug,bardoxolone methyl,1
Other,baseline message,1
Biological,bcg group,1
Biological,bcg vaccine (freeze-dried),1
Drug,bdb-001 injection,1
Behavioral,behavioral intervention.,1
Behavioral,behaviour change support,1
Behavioral,behaviour change technique intervention to improve quality of life,1
Drug,bemiparin,1
Drug,berberine,1
Drug,"best supportive care"" which includes antivirals",1
Drug,"best supportive care"" which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy",1
Drug,best symptomatic treatment based on doctor recommendations),1
Drug,bgb dxp593,1
Device,bidirectional oxygenation mouthpiece,1
Drug,bio101,1
Biological,biological test,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1
Biological,biological: oral polio vaccine,1
Device,biosensor,1
Procedure,biospecimen collection,1
Device,biovitals,1
Drug,bivalirudin injection,1
Drug,bld-2660,1
Procedure,blink,1
Procedure,blink/masseter inhibitory reflex,1
Biological,blood collection on admission,1
Biological,blood collection on admission/longitudinally,1
Biological,blood collection on their first consultation,1
Biological,blood collection on their first consultation/10 to 14 days later,1
Diagnostic Test,blood group determination,1
Diagnostic Test,blood sample for serological test,1
Other,blood/derivatives,1
Biological,bm-allo.msc,1
Drug,bms-986253,1
Biological,bnt162a1,1
Biological,bnt162b3,1
Biological,bnt162c2,1
Drug,brazilian green propolis extract (epp-af),1
Diagnostic Test,breath test,1
Diagnostic Test,breath test/cheek swab,1
Drug,brequinar,1
Behavioral,brief behavioral activation with mental imagery,1
Behavioral,brief cognitive behavioral therapy,1
Dietary Supplement,bromelain,1
Drug,bromhexine oral tablet and/or hydroxychloroquine tablet,1
Drug,broncho-vaxomâ®,1
Drug,btl-tml-covid,1
Drug,budesonide dry powder inhaler,1
Drug,c21,1
Drug,candesartan,1
Other,care as usual,1
Other,caring contacts,1
Other,cash transfer,1
Biological,castem,1
Biological,ccp,1
Drug,cd24fc,1
Biological,cell therapy protocol 1,1
Biological,cell therapy protocol 2,1
placebo,cellulose-containing placebo capsules,1
Drug,cenicriviroc,1
Drug,cenicriviroc (cvc),1
Device,centricyte 1000,1
Dietary Supplement,centrum adult (under 50) multivitamin,1
Drug,cerc-002,1
Other,certified cloth face mask,1
Other,certified cloth face mask/preventive information,1
Biological,chadox1 ncov-19 0.5ml boost,1
Behavioral,chat-based instant messaging support,1
Behavioral,chat-based support,1
Diagnostic Test,cheek swab,1
Other,chemokines profiles of patients with dexmedetomidine administration,1
Diagnostic Test,chest ct,1
Other,chest ct scan,1
Diagnostic Test,chest x-ray,1
Drug,chlorhexidine,1
Drug,ciclesonide inhalation aerosol,1
Other,cig axial,1
Other,cig tilted,1
Device,citrox,1
Drug,clarithromycin,1
Drug,clevudine,1
Procedure,clinical examination,1
Drug,clofazimine,1
Drug,cobicistat,1
Behavioral,cognitive,1
Behavioral,cognitive/behavioral intervention.,1
Drug,colchicine/herbal phenolic monoterpene fractions,1
Drug,colchicine/symptomatic treatment (paracetamol),1
Other,colgate periogard mouthwash,1
Other,colgate peroxyl mouthwash,1
Other,colgate total mouthwash,1
Drug,collagen-polyvinylpyrrolidone,1
Behavioral,combination,1
Combination Product,combination of oral polio vaccine,1
Combination Product,combination of oral polio vaccine/na-831,1
Other,communication type,1
Other,community health worker support,1
Other,community health workers.,1
Other,community interest message,1
placebo,comparable placebo,1
placebo,comparable placebo of drug,1
placebo,comparable placebo of oral polio vaccine,1
Combination Product,comparable placebo of oral polio vaccine/placebo of drug,1
Diagnostic Test,complement dosage,1
Drug,conestat alfa,1
Diagnostic Test,conjunctival swab/nasopharyngeal swab,1
Behavioral,contain covid anxiety ssi,1
Other,continuation of acei,1
Other,continuation of acei/arb,1
Other,continuation of arb,1
Drug,continuation of ras blocker,1
Device,continuous positive airway pressure,1
Other,control group (pharmacotherapy and,1
Other,"control group (pharmacotherapy and/or psychotherapy, n=10)",1
Other,control message,1
Device,control swab,1
Biological,convalescent anti-sars-cov-2 mbt plasma,1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",1
Device,conventional therapy first,1
Behavioral,coping strategies video,1
Device,core warming,1
Behavioral,cosh self-help smoking cessation booklet,1
Combination Product,cospherunate,1
Combination Product,cospherunate/azythromycine,1
Combination Product,cospherunate/phytomedicine/azythromycien,1
Behavioral,couples' group education,1
Diagnostic Test,covid-19 antigen,1
Diagnostic Test,"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",1
Biological,covid-19 convalescent plasma (ccp),1
Drug,covid-19 convalscent plasma,1
Diagnostic Test,"covid-19 igg / igm rapid test (whole blood, serum, plasma)",1
Other,covid-19 patients,1
Behavioral,covid-19 related health warning leaflet,1
Diagnostic Test,covid-19 swab,1
Behavioral,covid-specific advice,1
Biological,covid 19 convalescent plasma,1
Biological,covid19 convalescent plasma infusion,1
Biological,covid19 vaccine,1
Device,covsurf drug delivery system,1
Drug,cpi-006,1
Behavioral,crisis intervention therapy,1
Drug,crizanlizumab,1
Procedure,csvf,1
Diagnostic Test,ctus examination,1
Other,cupping,1
Other,current care per ucla treating physicians,1
Biological,cvncov vaccine,1
Biological,cyp-001,1
Diagnostic Test,cytokines,1
Drug,d,1
Drug,d followed by enoxaparin,1
Behavioral,daily coping toolkit,1
Behavioral,daily monitoring,1
Other,daily room disinfection,1
Procedure,dalargin,1
Drug,danoprevir,1
Drug,danoprevir/ritonavir,1
Drug,dapansutrile capsules,1
Drug,darunavir,1
Drug,darunavir/cobicistat,1
Drug,das181,1
Diagnostic Test,data collection/rhinopharyngeal swab,1
Drug,day,1
Drug,decitabine,1
Drug,deferoxamine,1
Drug,defibrotide,1
Drug,defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,1
Drug,degarelix,1
Drug,deglycyrrhizinated licorice,1
Other,derivatives.,1
Drug,desidustat,1
Combination Product,device),1
Drug,dexamethasone (high dose),1
Drug,dexamethasone/hydroxychloroquine,1
Device,dexcom,1
Drug,dfv890,1
Diagnostic Test,diagnostic,1
Diagnostic Test,diagnostic test covid-19,1
Diagnostic Test,diagnostic test for sars-cov2 for patients,1
Diagnostic Test,diagnostic test for sars-cov2 for patients/health staff,1
Diagnostic Test,diagnostic tests for covid-19 infection,1
Drug,dietary supplement containing resistant starch,1
Other,difficulties lived by disabled children's parents in the period of covid-19 pandemic,1
Other,dig axial,1
Other,dig tilted,1
Other,digital cardiac counseling,1
Behavioral,digital health online platform,1
Drug,diovan,1
Device,direct laryngoscope,1
Other,discontinuation of acei,1
Other,discontinuation of acei/arb,1
Other,discontinuation of arb,1
Drug,discontinuation of ras blocker,1
Other,distance learning,1
Drug,dociparastat sodium,1
Other,doppler echo,1
Drug,dornase alfa,1
Drug,double-blind nt-i7,1
Other,drugs,1
Other,drugs/supportive care,1
Drug,dur-928,1
Drug,dutasteride,1
Device,ðžxygen therapy,1
Behavioral,e-psychotherapy,1
Drug,early-dexamethasone,1
Drug,ec-18,1
Device,ecco2r,1
Other,economic benefit message,1
Other,economic freedom message,1
Drug,eculizumab,1
Other,education,1
Behavioral,educational video,1
Diagnostic Test,eeg,1
Other,eit-group,1
Drug,eltrombopag,1
Biological,emapalumab,1
Other,embarrassment message,1
Behavioral,emotional support plan,1
Drug,emtricitabine,1
Drug,emtricitabine/tenofovir disoproxil,1
Device,endoscopy,1
Drug,enoxaparin 1 mg,1
Drug,enoxaparin 1 mg/kg,1
Drug,enoxaparin/lovenox,1
Behavioral,enriched survey feedback,1
Drug,ensifentrine dose 1,1
Drug,enzalutamide,1
Diagnostic Test,ep,1
Biological,epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),1
Drug,escin,1
Drug,essential oils,1
Drug,estradiol,1
Drug,etoposide,1
Biological,exchange blood transfusion from normal donor,1
Procedure,exo 1 inhalation,1
Procedure,exo 2 inhalation,1
Drug,experimental group,1
Other,experimental: questionnaire without precaution information,1
Device,extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,1
Biological,f-652,1
Behavioral,family nurture intervention (fni),1
Other,farmalarm,1
Drug,favipiravir / standard care,1
placebo,favipiravir placebo,1
Drug,favipiravir/azithromycin,1
Drug,favipiravir/chloroquine,1
Drug,favipiravir/nitazoxanide,1
Drug,favipiravir/tocilizumab,1
Other,feces samples (covi-biome ancillary study),1
Other,fenofibrate,1
Diagnostic Test,filmarray pneumonia,1
Device,filtration test,1
Diagnostic Test,fingerstick,1
Drug,fingolimod,1
Drug,fisetin,1
Device,fit test,1
Device,flow controlled ventilation (evone-ventilator),1
Drug,fluoxetine,1
Drug,fluvoxamine,1
Drug,folic acid,1
Drug,fondapariniux,1
Drug,fondaparinux,1
Drug,formoterol,1
Device,freestyle libre 14 day cgm system,1
Drug,fuzheng huayu,1
Biological,gam-covid-vac lyo,1
Device,gammacoreâ® (vagus nerve stimulation),1
Device,gammacoreâ® sapphire (non-invasive vagus nerve stimulator),1
Drug,ganovo,1
Drug,ganovo/ritonavir//-interferon nebulization,1
Biological,"garadacimab, factor xiia antagonist monoclonal antibody",1
Drug,gargle,1
Other,gas exchanges at different peep,1
Drug,gc4419,1
Biological,gc5131,1
Behavioral,general health education,1
Drug,gimsilumab,1
Drug,gls-1200,1
Dietary Supplement,glycine,1
Device,go2 peep mouthpiece,1
Biological,grad-cov2,1
Drug,group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,1
Drug,guduchi ghan vati,1
Behavioral,guided online support program,1
Other,guilt message,1
Drug,gx-19,1
Behavioral,hads,1
Other,health enhancement program,1
Behavioral,health literacy,1
Diagnostic Test,health staff,1
Behavioral,health warning leaflet,1
Behavioral,healthy minds program foundations training,1
Other,hemodynamics changes at different peep,1
Drug,heparin sodium,1
Drug,herbal phenolic monoterpene,1
Biological,high-titer convalescent covid-19 plasma (ccp1),1
Device,high flow nasal cannula (hfnc),1
Behavioral,high intensity interval training group,1
Other,home-cov rule implementation,1
Device,home pulse oximetry monitoring,1
Behavioral,hope intervention,1
Biological,human amniotic fluid,1
Biological,human cord tissue mesenchymal stromal cells,1
Drug,hydrocortisone,1
Device,hydrogen oxygen generator with nebulizer,1
Drug,hydroxychloroquine / oxygen,1
Drug,hydroxychloroquine sulfate tablets/lopinavir/ ritonavir oral tablets,1
Combination Product,hydroxychloroquine/azithromycin/ tocilizumab,1
Drug,hydroxychloroquine/clindamycin,1
Drug,hydroxychloroquine/clindamycin/primaquine,1
Drug,hydroxychloroquine/doxycycline,1
Drug,hydroxyvitamin,1
Combination Product,hyperbaric oxygen,1
Drug,icatibant,1
Other,icu recovery,1
Other,icu recovery / physical therapy,1
Diagnostic Test,identification by pcr of the sars-cov-2 virus in samples taken from the fetus,1
Drug,ifx-1,1
Device,igg/igm rapid test,1
Drug,igiv,1
Biological,imm-101,1
Combination Product,immunofree tablets,1
Combination Product,immunofree tablets/reginmune capsule,1
Drug,indian costus,1
Drug,indomethacin,1
Other,inflammatory cytokines,1
Other,inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,1
Drug,infliximab,1
Biological,injection,1
Drug,inm005,1
Combination Product,inopulse,1
Drug,insulin,1
Drug,interferon-î² 1a,1
Drug,intermediate dose enoxaparin/ unfractionated heparin,1
Behavioral,intermittent,1
Behavioral,internet-based cognitive behavioral therapy,1
Behavioral,internet-based self-help,1
Behavioral,internet-based self-help after 3 weeks,1
Behavioral,internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1
Behavioral,intervention app,1
Behavioral,intervention group coronacope,1
Other,intervention group_rehabilitation program,1
Behavioral,intervention program,1
Other,interview by psychologists,1
Biological,intramuscular vaccine,1
Device,intraosseous,1
Device,intravenous,1
Drug,intravenous drug,1
Drug,iota-carrageenan,1
Drug,isoflurane inhalant product,1
Drug,itolizumab,1
Drug,iv dexamethasone,1
Drug,ivermectin (iver pâ®) arm will receive ivm 600 âµg,1
Drug,ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,1
Drug,ivermectin / chloroquine,1
Drug,ivermectin / doxycycline / placebo,1
Drug,ivermectin / placebo,1
Drug,ivermectin/doxycycline,1
Drug,ivig,1
Biological,kamada anti-sars-cov-2,1
Device,kelea water,1
Drug,ketamine,1
Drug,kg 24 hours continuous infusion for 15 days,1
Drug,kg once daily,1
Behavioral,kundalini yoga,1
Behavioral,kundalini yoga/anxiety reduction training,1
Dietary Supplement,lactobaciltus rhamnosus gg,1
Drug,lambda 180 mcg s.c,1
Procedure,laryngoscopy,1
Drug,late-dexamethasone,1
Drug,lau-7b,1
Drug,leaf-4l6715,1
Drug,leaf-4l7520,1
Drug,leflunomide,1
Other,let it out (lio)-c,1
Other,leukapheresis,1
Drug,levamisole,1
Drug,levamisole / budesonide/formoterol,1
Drug,levilimab,1
Drug,liberase enzyme,1
Dietary Supplement,licorice extract,1
Behavioral,lifestyle change promotion program,1
Device,limbix spark,1
Drug,linagliptin tablet,1
Drug,liposomal,1
Biological,longitudinally,1
Drug,lopinavir/ritonavir / hydoxychloroquine,1
Drug,losmapimod oral tablet,1
Drug,lovenox,1
Biological,low/upper respiratory tract sample,1
Diagnostic Test,lung impedance,1
Other,lung mechanics at different peep,1
Diagnostic Test,lung ultrasound use in patients hospitalized with covid,1
Biological,lv-smenp-dc vaccine,1
Biological,lv-smenp-dc vaccine/antigen-specific ctls,1
Drug,ly3127804,1
Drug,ly3832479,1
Drug,m-m-r ii â® vaccine,1
Drug,m5049,1
Other,magnetic resonance spectroscopy (mrs).,1
Other,maintenance,1
Device,makair,1
Dietary Supplement,manremyc,1
Drug,maraviroc,1
Device,marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),1
Drug,mas825,1
Device,mask,1
Procedure,masseter inhibitory reflex,1
Biological,matrix-m adjuvant - day 189 - phase 2,1
Biological,matrix-m adjuvant - phase 1,1
Biological,"matrix-m adjuvant, day 0 - phase 1",1
Biological,"matrix-m adjuvant, day 0 - phase 2",1
Biological,"matrix-m adjuvant, days 0",1
Biological,matrix-m1 adjuvant,1
Other,maximal effort test,1
Device,mcgrath videolaryngoscope,1
Drug,measles-mumps-rubella vaccine,1
Behavioral,mechanical ventilator settings/position,1
Other,media intervention,1
Procedure,meditation therapy,1
Behavioral,meditation/anxiety reduction training,1
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,1
Combination Product,mefloquine/azithromycin/ tocilizumab,1
Drug,melphalan,1
Biological,menacwy,1
Biological,menacwy boost,1
Biological,menacwy vaccine,1
Behavioral,mencare,1
Behavioral,mencare//bandebereho fathers'/couples' group education,1
Behavioral,mental well-being,1
Drug,meplazumab,1
Drug,merimepodib,1
Other,mesenchymal stromal cell-based therapy,1
Behavioral,messaging,1
Drug,metenkefalin,1
Drug,metenkefalin / tridecactide,1
Drug,methylene blue 5 mg,1
Drug,methylene blue 5 mg/ml,1
Drug,methylene blue/ vitamin c/n-acetyl cysteine,1
Biological,mf59 adjuvanted sars-cov-2 sclamp vaccine,1
Behavioral,mindfullness based cognitive program,1
Behavioral,mindfullness training,1
Behavioral,mindfulness,1
Other,mindfulness based intervention,1
Behavioral,mindfulness intervention,1
Behavioral,mindfulness session(s),1
Behavioral,minimal attention control intervention,1
Device,miniprobe alveoflex,1
Drug,ml intravenous solution [actemra]_#1,1
Drug,ml intravenous solution [actemra]_#1 (2 doses),1
Drug,ml prefilled syringe [kineret],1
Device,mls laser,1
Drug,mometasone furoate nasal spray,1
Diagnostic Test,monitoring visit,1
Combination Product,monoclonal antibody,1
Drug,montmorrillonite,1
Device,mouthrinse with bãªta-cyclodextrin,1
Device,mouthrinse with bãªta-cyclodextrin/citrox,1
Device,mouthrinse without bãªta-cyclodextrin,1
Device,mouthrinse without bãªta-cyclodextrin/citrox,1
Other,moxibustion,1
Other,moxibustion/cupping,1
Drug,mr,1
Drug,mr/m-m-r ii â® vaccine,1
Drug,mrx-4dp0004,1
Drug,mstt1041a,1
Drug,mucodentol,1
Biological,multistem,1
Drug,n-acetylcysteine,1
Combination Product,na-831/atazanavir,1
Combination Product,na-831and dexamethasone,1
Drug,nacl,1
Other,nacl solution,1
Drug,naltrexone,1
Diagnostic Test,nasal,1
Drug,nasal dexamethasone,1
Diagnostic Test,nasopharyngeal swabs,1
Behavioral,negative covid test result - hypothetical scenario,1
Device,neuromuscular,1
Other,neuromuscular electrical stimulation,1
Other,neutral writing control,1
Diagnostic Test,ng biotech,1
Diagnostic Test,ng test,1
Dietary Supplement,nicotinamide riboside,1
Drug,nigella sativa oil,1
Device,nioâ® (intraosseous access),1
Drug,nitazoxanide with ivermectin,1
Drug,nitric oxide-continuous,1
Drug,nitric oxide-continuous/sessions,1
Drug,nitric oxide-sessions,1
Device,nitric oxide delivered via lungfitâ„¢ system,1
Drug,nk-1r antagonist,1
Behavioral,no instruction regarding positioning,1
Device,non-contact mce system,1
Device,non-invasive red lllt treatment to chest of patient.,1
Behavioral,non-mindfulness intervention,1
placebo,"normal saline solution (nss), placebo - phase 1",1
placebo,"normal saline solution (nss), placebo - phase 2",1
placebo,"normal saline solution (nss), placebo, day 189 - phase 2",1
placebo,"normal saline solution (nss), placebo, day 21 - phase 1",1
placebo,"normal saline solution (nss), placebo, day 21 - phase 2",1
Other,not bravery message,1
Drug,np-120 (ifenprodil),1
Behavioral,nudge,1
Other,nutrition,1
Drug,nuvastatic,1
Other,observation,1
Other,obvio-19 app,1
Drug,olokizumab,1
Drug,omega-3 fatty acid supplement,1
Drug,omega 3,1
Drug,omega 3/nigella sativa oil,1
Drug,omega 3/nigella sativa oil/anise seed capsule,1
Drug,omega 3/nigella sativa oil/deglycyrrhizinated licorice,1
Drug,omega 3/nigella sativa oil/indian costus,1
Drug,omega 3/nigella sativa oil/quinine pills,1
Drug,omeprazole,1
Biological,one covid-19 vaccine candidate (tmv-083) administration - high dose,1
Behavioral,online intervention mental health covid-19,1
Behavioral,online support group,1
Drug,op-101,1
Behavioral,opt-in recruitment email,1
Behavioral,opt-out recruitment email,1
Diagnostic Test,optical coherence tomography (oct),1
Other,"or psychotherapy, n=10)",1
Drug,oral,1
Drug,oral co-trimoxazole,1
Biological,oral polio vaccine,1
Biological,oral polio vaccine / information,1
Dietary Supplement,oral supplement enriched in antioxidants,1
Drug,osoc,1
Biological,otilimab,1
Other,oxygen-ozone,1
Device,oxyhydrogen,1
Procedure,ozone,1
Drug,pacritinib,1
Drug,pamrevlumab,1
Drug,paracetamol,1
Drug,part 1 - tl-895,1
Drug,part 2 - tl-895,1
Behavioral,patient-centred advice on telephone consultation in tb patients:,1
Behavioral,patient education,1
Drug,pb1046,1
Device,pbmt,1
Device,pbmt/smf,1
Diagnostic Test,pcr/serology,1
Behavioral,peer resilience champion,1
Drug,pegylated interferon-î±2b,1
Biological,pembrolizumab,1
Diagnostic Test,performance evaluation,1
Device,performing of lung ultrasound,1
Other,personal freedom message,1
Device,personal protective equipment,1
Behavioral,personalized health education,1
Radiation,phase 1,1
Radiation,phase 2,1
Drug,phr160 spray,1
Other,physiotherapy,1
Combination Product,phytomedicine,1
Drug,pioglitazone,1
Drug,piperacillin,1
Drug,piperacillin/tazobactam,1
Drug,pirfenidone,1
placebo,placebo (0.9% normal saline),1
placebo,placebo (pb0),1
placebo,"placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)",1
placebo,placebo comparator: dw-ni,1
placebo,placebo comparator: dw-ns,1
placebo,placebo mouthwash (water),1
placebo,placebo of drug,1
placebo,placebo pmdi,1
Drug,placebo/control,1
Procedure,placenta-derived mmscs; cryopreserved placenta-derived multipotent mesenchymal stromal cells,1
Drug,plant polyphenol,1
Drug,plitidepsin,1
Biological,plx-pad,1
Drug,poractant alfa,1
Behavioral,position,1
Behavioral,positive covid test result - hypothetical scenario,1
Behavioral,positive feedback,1
Other,postural positioning,1
Drug,povidone,1
Drug,povidone-iodine 0.4% ni,1
Drug,povidone-iodine 0.5% ni,1
Drug,povidone-iodine 0.5% ns,1
Drug,povidone-iodine 0.6% ni,1
Drug,povidone-iodine 0.6% ns,1
Behavioral,prayer,1
Drug,prazosin,1
Other,prediction market,1
Dietary Supplement,preservision areds formulation gel tabs,1
Other,primary care,1
Other,probiorinse,1
Dietary Supplement,probiotics,1
Behavioral,problem-solving,1
Behavioral,problem-solving/relationship improvement intervention.,1
Procedure,procalcitonin,1
Drug,progesterone,1
Other,progressive cycling exercise test to exhaustion,1
Biological,prolastin,1
Drug,prophylactic,1
Drug,prophylactic heparin,1
Drug,prophylaxis,1
Drug,propofol,1
Device,prototype,1
Drug,proxalutamide,1
Other,psg,1
Other,psychoeducation,1
Other,psychoeducational intervention,1
Behavioral,psychological,1
Behavioral,psychological/behaviour change support,1
Drug,ptc299,1
Diagnostic Test,pulmonary anomalies 4 months after documented covid-19 pneumonia,1
Diagnostic Test,pulmonary function testing,1
Other,pulmonary physiotherapy techniques,1
Drug,pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),1
Diagnostic Test,pulse oximetry,1
Drug,pyridostigmine bromide,1
Biological,qazcovid-inâ® - covid-19 inactivated vaccine,1
Dietary Supplement,quadramune(tm),1
Other,quality-of-life assessment,1
Other,quality of life promotion,1
Drug,quinine pills,1
Combination Product,quinquina-stevia,1
Combination Product,quinquina-stevia/azythromycin,1
Drug,r tablets,1
Radiation,radiological,1
Drug,ramipril,1
Diagnostic Test,rapid detection test,1
Device,rapid onsite covid-19 detection,1
Diagnostic Test,rapid salivary test,1
Other,rapid serological test,1
Drug,razuprotafib,1
Drug,rbt-9 (90 mg),1
Behavioral,reading a book,1
Behavioral,recharge,1
Drug,recombinant human deoxyribonuclease (rh-dnase),1
Drug,recombinant human interferon î±2b spray,1
Drug,recombinant human plasma gelsolin (rhu-pgsn),1
Biological,recombinant interferon alfa-2b,1
Biological,recovered covid 19 patients plasma,1
Biological,rectal swab,1
Behavioral,referral card,1
Combination Product,reginmune capsule,1
Drug,regn10933 / regn10987,1
Drug,regn10933/regn10987,1
Other,regular care,1
Other,rehabilitation,1
Behavioral,relationship improvement intervention.,1
Behavioral,remain covid free ssi,1
Drug,remdesivir (rdv),1
Biological,remestemcel-l,1
Behavioral,remote cognitive behavioral therapy for insomnia,1
Other,removal of dead space filter,1
Drug,renin-angiotensin system inhibitors,1
Drug,"resp301, a nitric oxide generating solution",1
Other,respiratory function rehabilitation training,1
Biological,respiratory tract sample,1
Drug,rhace2,1
Diagnostic Test,rhinopharyngeal,1
Drug,rhtpo,1
Drug,rintatolimod,1
Drug,ritonavir/oseltamivir,1
Drug,roactemra,1
Procedure,robot assisted percutaneous cardiovascular intervention,1
Biological,rph-104,1
Drug,rtb101,1
Biological,sab-185,1
Other,saline-sodium citrate (ssc) buffer,1
Biological,saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,1
Other,saline with baby shampoo nasal irrigation,1
Drug,saline/standard care,1
Diagnostic Test,saliva specimen,1
Diagnostic Test,sample collection,1
Diagnostic Test,sample collection/performance evaluation (a),1
Diagnostic Test,sample collection/performance evaluation (b),1
Diagnostic Test,sampling of tissue,1
Drug,sar443122,1
Biological,sars-cov-2 antibody based ivig therapy,1
Other,sars-cov-2 infection,1
Diagnostic Test,"sars-cov-2 research in nasopharyngeal swab, sperm",1
Diagnostic Test,"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",1
Biological,sars-cov-2 rs - phase 1,1
Biological,sars-cov-2 rs/matrix-m adjuvant - day 189 - phase 2,1
Biological,sars-cov-2 rs/matrix-m adjuvant - phase 1,1
Biological,"sars-cov-2 rs/matrix-m adjuvant, day 0 - phase 1",1
Biological,"sars-cov-2 rs/matrix-m adjuvant, day 0 - phase 2",1
Biological,"sars-cov-2 rs/matrix-m adjuvant, days 0/21 - phase 2",1
Biological,sars-cov-2 rs/matrix-m1 adjuvant,1
Biological,sars-cov-2 specific t cells,1
Biological,sars-cov-2 vaccine (inactivated),1
Biological,sars-cov-2 vaccine formulation 1 with adjuvant 1,1
Biological,sars-cov-2 vaccine formulation 1 with adjuvant 2,1
Biological,sars-cov-2 vaccine formulation 2 with adjuvant 1,1
Biological,sars-cov-2 vaccine formulation 2 with adjuvant 2,1
Biological,sars-cov-2 vaccine formulation 2 without adjuvant,1
Biological,scb-2019,1
Biological,scb-2019 with as03 adjuvant,1
Biological,scb-2019 with cpg 1018 adjuvant,1
Biological,scb-2019 with cpg 1018 adjuvant/alum adjuvant,1
Device,scd,1
Other,sch intervention,1
Behavioral,self-compassion for chronic pain virtual group treatment program,1
Behavioral,self-help booklet,1
Other,self-interest message,1
Behavioral,self-management booklet (switch: stay well during covid-19),1
Behavioral,self-questionnary,1
Behavioral,self study,1
Drug,selinexor,1
Biological,serology sars-cov2,1
Other,serum,1
Drug,sessions,1
Drug,sevoflurane inhalant product,1
Device,sham device treatment,1
Behavioral,shg,1
Drug,sildenafil,1
Drug,sildenafil citrate,1
Drug,silymarin,1
Behavioral,simha kriya,1
Behavioral,simple cognitive task intervention,1
Drug,simvastatin,1
Drug,sirukumab,1
Dietary Supplement,sivomixx,1
Device,sledd with a l-mod,1
Device,smf,1
Behavioral,sms-based support,1
Behavioral,sms message support,1
Drug,sng001,1
Drug,soc / ifx-1,1
Drug,soc / intravenous famotidine,1
Drug,sodium bicarbonate,1
Drug,sofosbuvir/daclatasvir,1
Device,spartan covid-19 system,1
Other,spin-chat program,1
Other,staff wellbeing centres,1
Biological,standard-titer convalescent covid-19 plasma (ccp2),1
Other,standard interface,1
Other,standard of care (paracetamol),1
Drug,standard of care thromboprophylaxis,1
Drug,standard prophylactic dose enoxaparin,1
Drug,standard prophylactic dose enoxaparin/ unfractionated heparin,1
Other,standard treatment for covid-19,1
Procedure,stellate ganglion block,1
Combination Product,stem cells,1
Diagnostic Test,stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,1
Other,sudarshan kriya yoga (sky),1
Drug,sulfamethoxazole,1
Drug,sulodexide,1
Other,supine positioning,1
Drug,supportive/symptomatic treatment,1
Other,surgical facial mask,1
Other,suspension,1
Drug,suspension of heat killed (autoclaved) mycobacterium w,1
Other,suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,1
Biological,swab,1
Other,sweat samples (covidog ancillary study),1
Drug,symbicort,1
Drug,symptomatic treatment,1
Drug,symptomatic treatment (paracetamol,1
Drug,symptomatic treatment (paracetamol),1
Drug,symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),1
Biological,t cell derived exosom,1
Drug,t3 solution,1
Drug,tacrolimus,1
Device,tape-software,1
Drug,tazobactam,1
Device,tcc-covid mhealth,1
Drug,td139,1
Behavioral,tele-interventions related to diabetes management,1
Behavioral,tele-interventions related to diabetes management/mental well-being,1
Procedure,telephone follow-up,1
Behavioral,telesimulation,1
Drug,tenofovir disoproxil,1
Drug,tetrandrine,1
Other,the management of severe covid-19 cases,1
Other,therapeutic exercise,1
Other,therapeutic exercise/education,1
Drug,theraputic heparin,1
Behavioral,therapy intervention,1
Diagnostic Test,throat swab,1
Drug,thymalfasin,1
Drug,thymosin,1
Biological,tigeraseâ®,1
Biological,tigeraseâ®/best available care,1
Drug,tirofiban,1
Drug,tj003234,1
Drug,tociliuzumab,1
Drug,tocilizumab 20 mg/ml intravenous solution [actemra]_#1,1
Drug,tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),1
Drug,tofacitinib 10 mg,1
Procedure,tracheotomy,1
Drug,tradipitant,1
Drug,traditional chinese medicine,1
Other,training clinicians in basic critical care,1
Other,training clinicians in basic critical care/the management of severe covid-19 cases,1
Behavioral,"training for awareness, resilience,",1
Behavioral,"training for awareness, resilience,/action (tara)",1
Other,"training of youth, community health assistants",1
Other,"training of youth, community health assistants/community health workers.",1
Behavioral,training session adressing information,1
Behavioral,training session adressing information/health literacy,1
Drug,tranexamic acid,1
Device,transcutaneous auricular vagus nerve stimulation,1
Behavioral,transitional online peer support group (n=20),1
Diagnostic Test,transpulmonary pressure measurements,1
Behavioral,trauma-informed yoga video recording,1
Drug,treatment,1
Drug,treatment/prophylaxis,1
Drug,tridecactide,1
Drug,trimethoprim,1
Drug,trimethoprim/sulfamethoxazole,1
Other,trust in science message,1
Procedure,tsvf,1
Biological,two covid-19 vaccine candidate (tmv-083) administrations - high dose,1
Biological,two covid-19 vaccine candidate (tmv-083) administrations - low dose,1
Biological,"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1
Biological,"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1
Biological,"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1
Drug,txa127,1
Behavioral,ultra brief online mindfulness-based intervention,1
Biological,umbilical cord mesenchymal stem cells / heparin along with best supportive care.,1
Drug,umifenovir,1
Behavioral,unavailable covid test result - hypothetical scenario,1
Drug,unfractionated heparin iv,1
Drug,unfractionated heparin sc,1
Behavioral,unified protocol for covid-19 parenting stress (up-covid),1
Other,unsupervised physical activities,1
Other,usual antibiotic treatment,1
Behavioral,usual care positioning with no instructions,1
Drug,usual practice / symbicort rapihaler,1
Biological,utooth btc),1
Drug,uttr1147a,1
Biological,v-sars,1
Biological,v591,1
Biological,vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1
Biological,vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1
placebo,vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1
Drug,vadadustat,1
Other,vehicle,1
Other,vehicle / heparin along with best supportive care,1
Other,vehicle control,1
Drug,verapamil,1
Drug,veru-111,1
Drug,vib7734,1
Device,vibrolung,1
Other,video dance classes,1
Device,vielight rx plus,1
Biological,vir-7831,1
Other,virtual care at home,1
Behavioral,virtual group intervention,1
Device,virtual reality,1
Device,virtual reality therapy first,1
Device,viruxal oral,1
Device,viruxal oral/nasal spray,1
Dietary Supplement,vitamin b12,1
Drug,vitamin c tablets,1
Dietary Supplement,vitamins,1
Dietary Supplement,viusid,1
Dietary Supplement,viusid/asbrip,1
Device,volatile organic compounds analysis,1
Device,vv-ecmo,1
Device,vv-ecmo / cytokine adsorption,1
Device,water without an elevated level of kelea,1
Other,wearing surgical face mask sprayed with hypertonic saline,1
Other,weekly assessment,1
Behavioral,who recommendations (waiting condition),1
Other,woebot substance use disorder,1
Drug,xav-19,1
Drug,xcel-umc-beta,1
Behavioral,yoga group,1
Drug,zanubrutinib,1
Drug,zavegepant (bhv-3500),1
Drug,zidovudine,1
Drug,zilucoplanâ®,1
Dietary Supplement,zinc citrate,1
Drug,zithromax,1
Biological,zofin,1
